Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mohamed Hassan Elnaem, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri & Azarisman Shah Mohd Shah. (2019) Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings. Therapeutics and Clinical Risk Management 15, pages 137-145.
Read now
Read now
Ji-Hye Byun, Sun-Hong Kwon, Ji-Hye Ha & Eui-Kyung Lee. (2016) A benefit–risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients. Therapeutics and Clinical Risk Management 12, pages 965-974.
Read now
Read now
Lydie Marcelon, Thomas Verstraeten, Geraldine Dominiak-Felden & François Simondon. (2016) Quantitative benefit–risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in males. Expert Review of Vaccines 15:1, pages 139-148.
Read now
Read now
Ana Lozano-Blázquez, Cecilia Calvo-Pita, Mónica Carbajales-Álvarez, Patricio Suárez-Gil, Fernando Martínez-Martínez & Miguel Ángel Calleja-Hernández. (2014) Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice. Therapeutics and Clinical Risk Management 10, pages 527-535.
Read now
Read now
Articles from other publishers (9)
Chi Zhang, Er-Li Ma, Bing-Long Liu, Bin Wu, Zhi-Chun Gu & Hou-Wen Lin. (2022) Framework Development for Clinical Comprehensive Evaluation of Drugs–a Study Protocol Using the Delphi Method and Analytic Hierarchy Process. Frontiers in Pharmacology 13.
Crossref
Crossref
Mohamed A Baraka, Mohamed Hassan Elnaem, Ramadan Elkalmi, Adel Sadeq, Asim Ahmed Elnour, Royes Joseph Chacko, Abdullah H ALQarross & Mahmoud M AbdRabo Moustafa. (2021) Awareness of statin–food interactions using grapefruit as an example: a cross-sectional study in Eastern Province of Saudi Arabia. Journal of Pharmaceutical Health Services Research 12:4, pages 545-551.
Crossref
Crossref
Yee Vern Yong, Siti Hajar Mahamad Dom, Nurulmaya Ahmad Sa’ad, Rosliza Lajis, Faridah Aryani Md. Yusof & Jamalul Azizi Abdul Rahaman. (2021) Development and Practical Application of a Multiple-Criteria Decision Analysis Framework on Respiratory Inhalers: Is It Always Useful in the MOH Malaysia Medicines Formulary Listing Context?. MDM Policy & Practice 6:1, pages 238146832199406.
Crossref
Crossref
Ivett Jakab, Bertalan Németh, Baher Elezbawy, Melis Almula Karadayı, Hakan Tozan, Sabahattin Aydın, Jie Shen & Zoltán Kaló. (2020) Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses. Frontiers in Pharmacology 11.
Crossref
Crossref
Kevin Marsh, Praveen Thokala, Sitaporn Youngkong & Kalipso Chalkidou. (2018) Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings. Cost Effectiveness and Resource Allocation 16:S1.
Crossref
Crossref
Yuncui Yu, Lulu Jia, Yao Meng, Lihua Hu, Yiwei Liu, Xiaolu Nie, Meng Zhang, Xuan Zhang, Sheng Han, Xiaoxia Peng & Xiaoling Wang. (2017) Method Development for Clinical Comprehensive Evaluation of Pediatric Drugs Based on Multi-Criteria Decision Analysis: Application to Inhaled Corticosteroids for Children with Asthma. Pediatric Drugs 20:2, pages 195-204.
Crossref
Crossref
Daoud Al-Badriyeh, Ibrahim Alabbadi, Michael Fahey, Abdullatif Al-Khal & Manal Zaidan. (2016) Multi-indication Pharmacotherapeutic Multicriteria Decision Analytic Model for the Comparative Formulary Inclusion of Proton Pump Inhibitors in Qatar. Clinical Therapeutics 38:5, pages 1158-1173.
Crossref
Crossref
Tanatape Wanishayakorn & Surachat Ngorsuraches. (2016) Benefit-Risk Assessment of Statins (Lipid Lowering Agents): A Multi-Criteria Decision Analysis. Journal of Multi-Criteria Decision Analysis 23:1-2, pages 28-39.
Crossref
Crossref
Daoud Al-Badriyeh, Michael Fahey, Ibrahim Alabbadi, Abdullatif Al-Khal & Manal Zaidan. (2015) Statin Selection in Qatar Based on Multi-indication Pharmacotherapeutic Multi-criteria Scoring Model, and Clinician Preference. Clinical Therapeutics 37:12, pages 2798-2810.
Crossref
Crossref